Work

Factors affecting overall survival and progression-free survival in patients with metastatic castration resistant prostate cancer received 177Lu PSMA I&T therapy.

Year: 2024
Type: article
Source: PubMed
Language: English
Field: Medicine
Open Access status: closed
OpenAlex ID: W3112834866
FWCI: 0.458
Cites:
Cited by: 6
Related to: 10